- Home
- GOSS vs SNDL Comparison
GOSS vs SNDL Comparison
Compare GOSS & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- SNDL
- Stock Information
- Founded
- GOSS 2015
- SNDL 2006
- Country
- GOSS United States
- SNDL Canada
- Employees
- GOSS N/A
- SNDL N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- SNDL Pharmaceuticals and Biotechnology
- Sector
- GOSS Health Care
- SNDL Health Care
- Exchange
- GOSS Nasdaq
- SNDL Nasdaq
- Market Cap
- GOSS 586.6M
- SNDL 638.2M
- IPO Year
- GOSS 2019
- SNDL 2019
- Fundamental
- Price
- GOSS $2.94
- SNDL $2.48
- Analyst Decision
- GOSS Strong Buy
- SNDL Strong Buy
- Analyst Count
- GOSS 4
- SNDL 1
- Target Price
- GOSS $8.50
- SNDL $5.00
- AVG Volume (30 Days)
- GOSS 3.3M
- SNDL 5.2M
- Earning Date
- GOSS 11-06-2025
- SNDL 11-04-2025
- Dividend Yield
- GOSS N/A
- SNDL N/A
- EPS Growth
- GOSS N/A
- SNDL N/A
- EPS
- GOSS N/A
- SNDL N/A
- Revenue
- GOSS $40,237,000.00
- SNDL $692,339,389.00
- Revenue This Year
- GOSS N/A
- SNDL $5.52
- Revenue Next Year
- GOSS $30.65
- SNDL $4.09
- P/E Ratio
- GOSS N/A
- SNDL N/A
- Revenue Growth
- GOSS N/A
- SNDL 3.54
- 52 Week Low
- GOSS $0.66
- SNDL $1.15
- 52 Week High
- GOSS $2.98
- SNDL $2.74
- Technical
- Relative Strength Index (RSI)
- GOSS 76.74
- SNDL 65.18
- Support Level
- GOSS $2.41
- SNDL $2.37
- Resistance Level
- GOSS $2.71
- SNDL $2.62
- Average True Range (ATR)
- GOSS 0.19
- SNDL 0.14
- MACD
- GOSS 0.04
- SNDL -0.01
- Stochastic Oscillator
- GOSS 96.37
- SNDL 63.38
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.